LEISTON SURGERY
MAIN STREET, LEISTON
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 12 | 15 | 80.0% | |
| HF 4 | 2011 | 11 | 15 | 73.3% | |
| HF 4 | 2012 | 14 | 17 | 82.4% | |
| HF 4 | 2013 | 12 | 16 | 75.0% | |
| HF004 | 2014 | 3 | 4 | 75.0% | |
| HF004 | 2015 | 4 | 4 | 100.0% | |
| HF004 | 2016 | 6 | 6 | 100.0% | |
| HF004 | 2017 | 6 | 6 | 100.0% | |
| HF004 | 2018 | 6 | 6 | 100.0% | |
| HF004 | 2019 | 10 | 11 | 90.9% | |
| HF004 | 2020 | 11 | 11 | 100.0% | |
| HF006 | 2021 | 19 | 19 | 100.0% | |
| HF006 | 2022 | 24 | 27 | 88.9% | |
| HF006 | 2023 | 27 | 28 | 96.4% |
